TDP-43 pathology in Alzheimer's disease, dementia with Lewy bodies and ageing
- PMID: 27495267
- PMCID: PMC8029292
- DOI: 10.1111/bpa.12424
TDP-43 pathology in Alzheimer's disease, dementia with Lewy bodies and ageing
Abstract
Intracellular inclusions consisting of TAR DNA binding protein-43 (TDP-43 pathology) are present in up to 57% of Alzheimer's disease (AD) cases and follow a distinct topographical pattern of progression described in the TDP-43 in AD staging scheme. This scheme has not been applied to the assessment of TDP-43 pathology in dementia with Lewy bodies (DLB) and aged controls. We investigated TDP-43 pathology prevalence and severity in AD, DLB, mixed AD/DLB (Mx AD/DLB) and aged controls. One hundred and nineteen human post-mortem brains were included, neuropathologically diagnosed as AD: 46, DLB: 15, Mx AD/DLB: 19 and aged controls: 39. Paraffin sections inclusive of the amygdala, hippocampus, striatum and neocortex were immunohistochemically stained with antibodies against phosphorylated TDP-43 and staged according to the TDP-43 in AD staging scheme. TDP-43 pathology was present in all groups: AD: 73.9%, DLB: 33.3%, Mx AD/DLB: 52.6% and controls: 17.9%. Prevalence of TDP-43 pathology was significantly higher in AD and Mx AD/DLB compared to controls. In controls, higher age at death was associated with prevalence of TDP-43 pathology and higher TDP-43 in AD stage, suggesting that this type of TDP-43 pathology may partly be an age-associated phenomenon. Significantly higher prevalence of TDP-43 pathology in the AD group indicates that AD pathology possibly triggers and aggravates TDP-43 pathology. The validity of the TDP-43 in AD staging scheme is not limited to AD and should be applied to assess TDP-43 pathology in post mortem brains of aged individuals to further elucidate the role of TDP-43 pathology in age associated neurodegeneration.
Keywords: Alzheimer's disease; Lewy body diseases; TDP-43; ageing; dementia with Lewy bodies; hippocampal sclerosis; mixed Alzheimer's disease and dementia with Lewy bodies.
© 2016 International Society of Neuropathology.
Conflict of interest statement
The authors declare they have no conflict of interest.
Figures


Similar articles
-
Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies.Brain Res. 2007 Dec 12;1184:284-94. doi: 10.1016/j.brainres.2007.09.048. Epub 2007 Oct 25. Brain Res. 2007. PMID: 17963732
-
Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes.Acta Neuropathol. 2015 May;129(5):729-48. doi: 10.1007/s00401-015-1406-3. Epub 2015 Mar 11. Acta Neuropathol. 2015. PMID: 25758940
-
Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies.Acta Neuropathol. 2009 Feb;117(2):125-36. doi: 10.1007/s00401-008-0480-1. Epub 2009 Jan 13. Acta Neuropathol. 2009. PMID: 19139911
-
The Differential Effects of Alzheimer's Disease and Lewy Body Pathology on Cognitive Performance: a Meta-analysis.Neuropsychol Rev. 2017 Mar;27(1):1-17. doi: 10.1007/s11065-016-9334-0. Epub 2016 Nov 22. Neuropsychol Rev. 2017. PMID: 27878426 Review.
-
Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.J Neural Transm (Vienna). 2018 Apr;125(4):615-650. doi: 10.1007/s00702-017-1821-9. Epub 2017 Dec 8. J Neural Transm (Vienna). 2018. PMID: 29222591 Review.
Cited by
-
CRISPR screen for protein inclusion formation uncovers a role for SRRD in the regulation of intermediate filament dynamics and aggresome assembly.PLoS Genet. 2024 Feb 5;20(2):e1011138. doi: 10.1371/journal.pgen.1011138. eCollection 2024 Feb. PLoS Genet. 2024. PMID: 38315730 Free PMC article.
-
Pathway from TDP-43-Related Pathology to Neuronal Dysfunction in Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration.Int J Mol Sci. 2021 Apr 8;22(8):3843. doi: 10.3390/ijms22083843. Int J Mol Sci. 2021. PMID: 33917673 Free PMC article. Review.
-
The Role of TDP-43 in Neurodegenerative Disease.Mol Neurobiol. 2022 Jul;59(7):4223-4241. doi: 10.1007/s12035-022-02847-x. Epub 2022 May 2. Mol Neurobiol. 2022. PMID: 35499795 Review.
-
Structural (dys)connectivity associates with cholinergic cell density in Alzheimer's disease.Brain. 2022 Aug 27;145(8):2869-2881. doi: 10.1093/brain/awac093. Brain. 2022. PMID: 35259207 Free PMC article.
-
Associations Between Loneliness and Cognitive Resilience to Neuropathology in Older Adults.J Gerontol B Psychol Sci Soc Sci. 2023 May 26;78(6):939-947. doi: 10.1093/geronb/gbad023. J Gerontol B Psychol Sci Soc Sci. 2023. PMID: 36789449 Free PMC article.
References
-
- Arai T, Mackenzie IR, Hasegawa M, Nonoka T, Niizato K, Tsuchiya K et al (2009) Phosphorylated TDP‐43 in Alzheimer's disease and dementia with Lewy bodies. Acta Neuropathol 117:125–136. - PubMed
-
- Braak H, Braak E (1991) Neuropathological stageing of Alzheimer‐related changes. Acta Neuropathol 82:239–259. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical